Top Smart Score Stocks
Analysts' Top Stocks
Insiders' Hot Stocks
Daily Stock Ratings
Daily Insider Transactions
Electronic Vehicles Stocks
Coronavirus Vaccine Stocks
High Dividend Stocks
My Portfolio Analysis
Profile & Performance
My Public Profile
Find & Follow Experts
Top 25 Wall Street Analysts
Top 25 Financial Bloggers
Top 25 Corporate Insiders
Top 25 Hedge Fund Managers
Top Individual Investors
Ideas & Insights
Calendars & Events
Stock Market Holidays
Become an Affiliate
Plans & Pricing
Better Days Are on the Horizon for Aurinia Stock, Says Analyst
Usually, biopharma stocks are inclined to surge or crash based on regulatory decisions or the outcome of clinical...
May 10, 2021
Aurinia’s Kidney Disease Treatment Wins FDA Approval; Street Sees 78% Upside
Aurinia Pharmaceuticals announced that the US Food and Drug Administration (FDA) has approved its Lupkynis (voclosporin) treatment for...
Jan 25, 2021
Aurinia Inks Voclosporin Deal With Otsuka For Europe, Japan; Analyst Sees 53% Upside
Aurinia Pharmaceuticals has inked a collaboration and license agreement with Japan’s Otsuka Pharmaceutical Co. for the development and...
Dec 20, 2020
Aurinia Stock to Surge by 80%? This 5-Star Analyst Thinks It’s Possible
Aurinia Pharmaceuticals (AUPH) reported Q3 earnings this week. Apart from getting a glimpse into the state of overall...
Nov 13, 2020
Aurinia: Voclosporin Opportunity Still Intact
To say that in contrast to the result, there wasn’t a dry eye in the house after Aurinia...
Nov 04, 2020
Aurinia Tanks 10% As Dry Eye Trial Fails To Reach Primary Endpoint
Shares in Aurinia Pharmaceuticals (AUPH) tanked 10% after-hours after the biopharma announced disappointing topline data from the Phase...
Nov 03, 2020
Aurinia Pharma Surges 9% On Priority Review For Lupus Kidney Treatment
Shares in Aurinia Pharma (AUPH) surged 9% in Tuesday’s extended trading after the U.S. Food and Drug Administration...
Jul 22, 2020
Aurinia Submits FDA New Drug Admission For Novel Voclosporin Kidney Treatment
Shares in Aurinia Pharmaceuticals, Inc (AUPH) advanced in pre-market trading as the biotech company announced the submission of...
May 26, 2020
Billionaire Jim Simons Pulls the Trigger on These 3 Healthcare Stocks
Despite COVID-19’s devastating impact, one legendary stock picker might have just cracked the market code. While the broader...
May 20, 2020